Liang Peir-In, Chang Sheng-Tsung, Lin Ming-Yen, Hsieh Yen-Chuan, Chu Pei-Yi, Chen Chih-Jung, Lin Kai-Jen, Jung Yun-Chih, Hwang Wei-Shou, Huang Wen-Tsung, Chang Wei-Chin, Ye Hongtao, Chuang Shih-Sung
Department of Pathology, Kaohsiung Medical University Hospital, Kaohsiung Medical University Kaohsiung, Taiwan.
Department of Pathology, Chi-Mei Medical Center and Department of Nursing, National Tainan Institute of Nursing Tainan, Taiwan.
Int J Clin Exp Pathol. 2014 Aug 15;7(9):6097-107. eCollection 2014.
Angioimmunoblastic T-cell lymphoma (AITL) is an aggressive peripheral T-cell lymphoma (PTCL) of follicular helper T-cell origin and is rare in Taiwan. There are overlapping features of AITL and peripheral T-cell lymphoma with a follicular growth pattern (PTCL-F). Around one fifth of PTCL-F exhibits t(5;9)(q33;q22)/ITK-SYK chromosomal translocation, which is essentially absent in AITL. We retrospectively investigated 35 cases of AITL from Taiwan with histopathology review, immunohistochemistry, in situ hybridization for Epstein-Barr virus (EBV) and fluorescence in situ hybridization (FISH) for t(5;9)(q33;q22)/ITK-SYK and correlated the results with overall survival. Twenty-six cases of not otherwise specified PTCL (PTCL-NOS) were also examined by FISH for comparison. Most AITL patients were male (69%) and elderly (median age at 67 years) with frequent bone marrow involvement (53%), high Ann Arbor stages (77%), and elevated serum lactate dehydrogenase (68%). Most cases (80%) showed a typical CD4+/CD8- phenotype and in 90% cases there were scattered EBV-positive B-cells (less than 10% cells). None of these cases showed t(5;9)(q33;q22)/ITK-SYK translocation by FISH. Gain of ITK and SYK gene was identified in 38% and 14% tumors, respectively, but both were not associated with overall survival. Performance status < 2 was associated with a better outcome but not the other clinicopathological factors. All PTCL-NOS cases were negative for ITK-SYK translocation with similar rates (38% and 12%, respectively) of gains at ITK and SYK loci as that of AITL. In this so far the largest series of AITL from Taiwan, we reported the clinicopathological features and FISH findings on ITK and SYK genes. We confirmed the absence of t(5;9)(q33;q22)/ITK-SYK translocation, which may serve as an additional differential diagnostic tool from PTCL-F when present. PTCL-NOS shared a similar pattern of ITK and SYK gains with AITL. More studies are warranted to elucidate the roles of SYK and ITK and other genes in the lymphomagenesis of AITL in Taiwan.
血管免疫母细胞性T细胞淋巴瘤(AITL)是一种起源于滤泡辅助性T细胞的侵袭性外周T细胞淋巴瘤(PTCL),在台湾较为罕见。AITL与具有滤泡生长模式的外周T细胞淋巴瘤(PTCL-F)有重叠特征。约五分之一的PTCL-F表现出t(5;9)(q33;q22)/ITK-SYK染色体易位,而AITL基本不存在这种情况。我们对来自台湾的35例AITL病例进行了回顾性研究,进行了组织病理学检查、免疫组化、爱泼斯坦-巴尔病毒(EBV)原位杂交以及t(5;9)(q33;q22)/ITK-SYK荧光原位杂交(FISH),并将结果与总生存期相关联。还对26例未另行特指的PTCL(PTCL-NOS)病例进行了FISH检查以作比较。大多数AITL患者为男性(69%)且年龄较大(中位年龄67岁),常伴有骨髓受累(53%)、Ann Arbor分期较高(77%)以及血清乳酸脱氢酶升高(68%)。大多数病例(80%)表现出典型的CD4+/CD8-表型,90%的病例中有散在的EBV阳性B细胞(细胞数少于10%)。这些病例通过FISH均未显示t(5;9)(q33;q22)/ITK-SYK易位。分别在38%和14%的肿瘤中检测到ITK和SYK基因增益,但两者均与总生存期无关。体能状态<2与较好的预后相关,而其他临床病理因素则不然。所有PTCL-NOS病例的ITK-SYK易位均为阴性,ITK和SYK基因座增益率与AITL相似(分别为38%和12%)。在这项目前来自台湾的最大系列AITL研究中,我们报告了其临床病理特征以及ITK和SYK基因的FISH检测结果。我们证实了不存在t(5;9)(q33;q22)/ITK-SYK易位,当存在这种易位时,它可作为与PTCL-F鉴别的额外诊断工具。PTCL-NOS与AITL在ITK和SYK增益模式上相似。需要更多研究来阐明SYK和ITK以及其他基因在台湾AITL淋巴瘤发生中的作用。